| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |